Open AccessA Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis
Author(s) -
Adelaide A. Hebert,
Debbie Glaab,
Rhonda Schreiber
Publication year - 2019
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.3.2.11
Subject(s) - tolerability , plaque psoriasis , pharmacokinetics , medicine , pharmacodynamics , pharmacology , open label , psoriasis , adverse effect , dermatology
not available. Disclosures: Study sponsored by Mayne Pharma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom